Health

Global Mpox Vaccine Stockpile to Open for Outbreak Response Health

Global Mpox Vaccine Stockpile to Open for Outbreak Response

WHO and partners are launching a Gavi-funded global mpox vaccine reserve this month to speed equitable access during outbreaks.

0
WHO Targets Childhood Sickle Cell Deaths With Medicine Access Drive Health

WHO Targets Childhood Sickle Cell Deaths With Medicine Access Drive

WHO links new clinical guidance, paediatric hydroxyurea standards and medicine prequalification to reduce preventable sickle cell deaths among children.

0
Congo Ebola Outbreak Tops 6,000 Confirmed Cases Health

Congo Ebola Outbreak Tops 6,000 Confirmed Cases

Congo reported 6,041 confirmed Bundibugyo Ebola cases and 2,911 deaths as health agencies raced to contain the record-fast outbreak.

0
WHO urges evidence-led integration of African traditional medicine Health

WHO urges evidence-led integration of African traditional medicine

WHO calls for research, regulation and investment to integrate traditional medicine safely into African health systems.

0
STAREE trial finds atorvastatin cuts major heart events in healthy older adults Health

STAREE trial finds atorvastatin cuts major heart events in healthy older adults

The 9,971-person STAREE trial found 40 mg of atorvastatin reduced major cardiovascular events by 30% in healthy adults aged 70 or older, without significantly improving disability-free survival.

0
Congo Ebola outbreak expands to 60 health zones Health

Congo Ebola outbreak expands to 60 health zones

WHO says Congo's Bundibugyo Ebola outbreak has reached 60 health zones, with 5,794 confirmed cases and 2,786 deaths.

0
FDA Approves First Oral Treatment for Adult Dermatomyositis Health

FDA Approves First Oral Treatment for Adult Dermatomyositis

The FDA approved once-daily brepocitinib as the first oral therapy specifically indicated for adults with the rare autoimmune disease dermatomyositis.

0
FDA Approves First RAS-Targeted Drug for Metastatic Pancreatic Cancer Health

FDA Approves First RAS-Targeted Drug for Metastatic Pancreatic Cancer

The FDA has approved daraxonrasib, the first RAS-targeted therapy for metastatic pancreatic cancer, after a 500-patient trial nearly doubled median survival versus chemotherapy.

0
FDA Authorizes First Continuous Glucose and Ketone Wearable Health

FDA Authorizes First Continuous Glucose and Ketone Wearable

The FDA authorized Abbott's Libre Duo 10 Day for people with diabetes aged two and older, creating the first wearable to continuously track glucose and ketones together.

0
FDA Approves First Treatment for Rare Autoimmune Blood Disorder Health

FDA Approves First Treatment for Rare Autoimmune Blood Disorder

The FDA cleared Imaavy for patients aged 12 and older with warm autoimmune hemolytic anemia, creating the first approved treatment specifically for the rare disease.

0
WHO warns Congo Ebola response must scale up at 100-day mark Health

WHO warns Congo Ebola response must scale up at 100-day mark

WHO says Ebola transmission in Congo is outpacing control efforts 100 days after the outbreak declaration, despite a major expansion of testing and treatment capacity.

0
Multilingual Speakers Show Younger Brain Activity in New Study Health

Multilingual Speakers Show Younger Brain Activity in New Study

Conference research links speaking more languages with younger estimated brain activity, while researchers caution that the study does not prove causation or dementia prevention.

0

No articles found